# Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

> **NCT07336238** · PHASE2 · RECRUITING · sponsor: **University of Washington** · enrollment: 18 (estimated)

## Conditions studied

- Anxiety
- Depression
- Hematopoietic and Lymphatic System Neoplasm
- Metastatic Malignant Solid Neoplasm

## Interventions

- **BEHAVIORAL:** Psychotherapy
- **DRUG:** Psilocybin
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT07336238
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-15
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07336238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07336238, "Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07336238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*